IQVIA HOLDINGS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was -$40.00M.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $45.00M, a 4400.00% increase year-over-year.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was -$35.00M.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for fiscal 2025 was -$8.00M, a 112.12% decline from fiscal 2024.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for fiscal 2024 was $66.00M, a 8.20% increase from fiscal 2023.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for fiscal 2023 was $61.00M, a 14.08% decline from fiscal 2022.
- IQVIA HOLDINGS INC. stock issued during period, value, new issues for fiscal 2022 was $71.00M, a 20.34% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | -$40.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$8.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $45.00M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-10-28 | |
| 2025-03-31 | -$35.00M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $66.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $1.00M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $1.00M 10-Q · filed 2025-10-28 | |
| 2024-03-31 | -$61.00M 10-Q · filed 2025-10-28 | |
| 2023-12-31 | $61.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $58.00M 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $71.00M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $58.00M 10-Q · filed 2024-05-02 | |
| 2022-06-30 | $2.00M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $67.00M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $59.00M 10-K · filed 2024-02-15 | |
| 2021-09-30 | $4.00M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $1.00M 10-Q · filed 2022-10-27 | |
| 2021-03-31 | -$57.00M 10-Q · filed 2022-10-27 | |
| 2020-12-31 | -$44.00M 10-K · filed 2023-02-15 | |
| 2020-09-30 | -$3.00M 10-Q · filed 2021-10-22 | |
| 2020-06-30 | $1.00M 10-Q · filed 2021-10-22 | |
| 2020-03-31 | -$44.00M 10-Q · filed 2021-10-22 | |
| 2019-12-31 | $11.00M 10-K · filed 2022-02-16 | |
| 2019-09-30 | -$4.00M 10-Q · filed 2020-10-22 | |
| 2019-06-30 | $8.00M 10-Q · filed 2020-10-22 | |
| 2019-03-31 | $5.00M 10-Q · filed 2020-10-22 | |
| 2018-12-31 | $11.00M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $15.00M 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $14.00M 10-Q · filed 2019-11-01 | |
| 2018-03-31 | -$5.00M 10-Q · filed 2019-11-01 | |
| 2016-12-31 | $10.52B 10-K · filed 2019-02-19 | |
| 2015-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $65.00M 10-K · filed 2018-02-16 |
| 2014-12-31 | $35.00M 10-K · filed 2017-02-16 | |
| 2013-12-31 | $537.54M 10-K · filed 2016-02-11 | |
| 2012-12-31 | $3.47M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $1.11M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |